Vascepa, also known as icosapent ethyl, is a prescription medication used to lower triglyceride levels in the blood. It works by reducing the amount of triglycerides produced by the liver and increasing the breakdown of existing triglycerides [3]. According to Drug Patent Watch, Vascepa was first approved by the FDA in 2012 [1].

GoodRx notes that Vascepa has been shown to significantly reduce triglyceride levels in clinical studies [2]. In a study called MARINE, Vascepa was found to reduce triglyceride levels by 33% compared to placebo [2]. In another study called ANCHOR, Vascepa was found to reduce triglyceride levels by 21% compared to placebo [2].

However, it's important to note that Vascepa is not effective for everyone. According to Verywell Health, Vascepa is most effective for patients with very high triglyceride levels (500 mg/dL or higher) [3]. Additionally, Vascepa may not be effective for patients with certain medical conditions, such as pancreatitis [3].

In summary, Vascepa has been shown to be effective for reducing triglyceride levels in clinical studies, particularly in patients with very high triglyceride levels. However, it may not be effective for everyone and should be used under the guidance of a healthcare professional [2][3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.goodrx.com/icosapent-ethyl/lovaza-vascepa-lowering-triglycerides
[3] https://www.verywellhealth.com/basic-information-about-vascepa-icosapent-ethyl-698258